FLInt protocol_NM

The protocol describes how to use the Fluorescent Landmark Interference: FLInt method to integrated transgene in C. elegans, from the selection of background strains, preparation of injection mix, and animal screening. The procedure follows the principle of the site-target DNA excise via CRISPR/Cas9 at the fluorescent marker sites described in our publication (Malaiwong et al., 2023). The FLInt protocol for integration covers the establishment of the transgenic C. elegans from (1) the newly forming extrachromosomal array, (2) the existing array, and (3) the integrated Cas9 gene.

EG7835 [oxTi556 I (eft-3p::tdTomato::H2B)]

EG7866 [oxTi564 II (eft-3p::tdTomato::H2B)]

EG7898 [oxTi619 III (eft-3p::tdTomato::H2B)]

EG7911 [oxTi705 IV (eft-3p::tdTomato::H2B)]

EG7944 [oxTi553 V (eft-3p::tdTomato::H2B)]

EG7989 [oxTi668 X (eft-3p::tdTomato::H2B)]

EG8888 [oxTi936 X (eft-3p::gfp::NLS)]

EG8958 [oxTi1022 I (eft-3p::gfp::NLS)]

E. coli (OP50)

Plasmids

plasmid of interest

co-injection marker plasmid, myo-2p::mCherry, myo-3p::mCherry, unc-122p::GFP

CRISPR reagents

crRNA against tdTomato (5´- 64 GTGATGAACTTCGAGGACGG|CGG-3’)

crRNAs against GFP (5´-CTTGTCACTACTTTCTGTTA-3´) and (5´-TGAACTATACAAATGCCCGG-3´)

tracrRNA

Cas9 nuclease

Chemicals

DNA ladder (invitrogen)

Chemicals for preparing NGM plates

Halocarbon oil

Agarose

5-cm petri dish

3-cm petri dish

Coverslip

Painting brush

Fluorescent stereoscope

Microinjector apparatus

Needle puller

Loading pipette tip

Glass capillary

Worm picker (made from the platinum wire)

20C incubator

25C incubator

Thermoblock

The selection of background strains for integration depends on the desired landing site for the transgene of interest. Based on the data from the article, the landing site at the center of each chromosome are recommended based on the high effeciency and success.

Integration on Chromosome I: use EGxxx

Integration on Chromosome II

Integration on Chromosome III

Integration on Chromosome IV

Integration on Chromosome V

Integration on Chromosome X

The parental strains should be cultured at 20C in order to prevent the systemic defects caused by the tdTomato gene. In addition, non-contaminated OP50 is preferable.

(The concentration of crRNA in this protocol has been adjusted from the protocol showed in the article)

Prepare the stock solution of crRNA and tracrRNA to obtain 167 mM by adding milliQ water

Mix 1 uL of crRNA and 1 uL of tracrRNA in a 1.5 mL tube

Adjust the volume up to 9 uL by milliQ water

Incubate the solution at 95C for 5 min using the Thermoblock

Incubate the solution at RT for 5 min

Add 1 uL of Cas9 nuclease

Aliquot the mix into the PCR tube (2 uL each)

Store at -20C for the further use

Mix the plasmid of interest and co-injection marker to obtain the desired concentration

Add the DNA ladder (initial conc. = 500 ng/uL) to obtain 100 ng/uL of total DNA

Add milliQ water up to 8 uL

Add the CRISPR mix (in the PCR tube described above) (total vol. = 10 uL)

Spin the mix using the centrifuge at the high speed for 8-10 min to prevent the debris in the microneedle

Melt the 1.5-2% agarose in milliQ water

Drop the melted agarose onto the center of the coverslip (size=)

Put another coverslip on top until the agarose cool down and solidify

Remove one of the coverslip

Dry the agarose pad (on the coverslip) at room temperature overnight

Keep the pad in the clean and dry place

Prepare the microneedle by pulling the cappillary using the needle puller

Pipette 2-5 uL injection mix (described above) using the loading tip

Load the mix into the needle

Setup the microneedle into the microinjector apparatus

Select 20-30 young, healthy adult worms from the culture plate using painting brush and halocarbon oil

Place the worms onto the NGM plate without OP50 (30-min starvation before injection is optional, it facilitates visualizing gonads with less intestinal contents)

Transfer worms to the injection pad using painting brush with halocarbon oil

Flatten worms on the injection pad by completyly attach to the injection pad (worms will not move)

Place the injection pad on the microinjector stage

Adjust the focal plane of the microneedle and worm's gonad with 40X objective lens view

Move the microneedle by the micromanipulator against the worm or move the stage against the needle

Penetrate the needle into the worm when the needle and the gonad arm are in the same plane

Apply the air pressure to push the solution into the gonad (the successful injection can be observed by the movement of the syncytial nuclei toward the solution flow)

Inject in both gonad arms of each worm

Recover the injected worms by dropping M9 buffer into the injection pad (worms will be rehydrated, detach from the pad, and start moving)

Transfer 10 injected worms into the 5-cm NGM plate with OP50 (20-30 worms are recommended for each integration)

Incubate at 25C for 3 days

The positive F1 will be obtained by the following steps:

Screen for the worms that lost the tdTomato signals but express the co-injection marker protein from the plate

Single them out into the 3-cm petri dish with NGM/OP50

Note the number of transgenic lines (= number of positive F1)

Culture F1 in 25C incubator

From each F1 plate, screen for the F2(s) with high transmission frequency (high proportion of co-injection marker expression worms)

Discard the plate without extrachromosomal array transmission or less than 50%

Collect the plate with approx. 75% transmission frequency

From each plate, single out six positive F2 into new 3-cm petri dish with NGM/OP50

Label each six plates(F3) from the same origin(F2) as the same transgenic line

Culture F2 in 25C incubator

Screen all plates from day 6 using the fluorescent stereoscope

Search for the 100% transgenic F3 progenies from each line (6 plates)

Calculate the integration efficiency by (no. of integrated line / no. of positive F1) x 100

The integrated lines can then be used for experiment

To reduce the cost of gene editing reagents, using the genetically-encode protein or RNA became the reliable option. Here, we adapted the C. elegans strain, EG9615, expressing Cas9 protein in the germ line with the optimizing intron for the robust expression and efficiency (ref.) With such background P0 animal, we injected the CRISPR mix which made by the crRNA and tracrRNA and proceed the screening step as previously described. This strategy can eliminate the use of purified Cas9 from purchasing, also, we could sustainably obtain such protein in the worms in all generations. However, the integrated Cas9 is not preferable for the further use. After obtaining the candidate, the integrated Cas9 allele (oxSi1091[Pmex-5::cas9(+smu-2 introns)::tbb-2 3'UTR unc-119+] II) should be discarded from the integrated array by outcrossing with N2.

The procedure of worm selection, microinjection, and screening are similar to the previous method. However, the preparation of the CRISPR mix is different.

Prepare the stock solution of crRNA and tracrRNA to obtain 167 mM by adding milliQ water

Mix 1 uL of crRNA and 1 uL of tracrRNA in a 1.5 mL tube

Adjust the volume up to 10 uL by milliQ water

Incubate the solution at 95C for 5 min using the Thermoblock

Incubate the solution at RT for 5 min

Aliquot the mix into the PCR tube (2 uL each)

Store at -20C for the further use

With the variation and inconsistency of gene expression of an array, the preliminary observation of expression pattern is required prior to integration. This protocol is an alternative integration using FLInt for the selected extrachromosomal lines.

Select the plasmid for injection or co-injection plasmid with Amp resistance gene

Prepare the injection mix by adding plasmid of interest, co-injection marker plasmid, and DNA ladder (100 ng of DNA in total)

Inject into the P0 strain (such as N2)

Screen and isolate the F1 progenies with co-injection marker expression

Observe the gene expression from the transmitted array in F2 progenies

Cross the extrachromosomal transgenic line with the selected tdTomato landing site, for example, the EG7944 for chromosome V integration

Prepare the stock solution of crRNAs and tracrRNA to obtain 167 mM by adding milliQ water

Mix 1 uL of crRNA (tdTomato), 1 uL of crRNA (AmpR) and 2 uL of tracrRNA in a 1.5 mL tube

Adjust the volume up to 9 uL by milliQ water

Incubate the solution at 95C for 5 min using the Thermoblock

Incubate the solution at RT for 5 min

Add 1 uL of Cas9 nuclease

Aliquot the mix into the PCR tube (2 uL each)

Store at -20C for the further use

Prepare the injection mix by diluting the CRISPR mix (2 uL) with 8 uL miliQ water

Inject the solution into the gonad of the P0 strain (tdTomato (V) + extrachromosomal array)

Culture the P0 animals in 25°C

Screen and single out the positive F1 (co-injection marker positive + non-tdTomato)

Culture the F1 progenies for 3 days in 25°C

Screen for the high transmitted array (75%) in F2 population and single out six worms from each selected plate

Culture the F2 progenies for 3 days in 25°C

Screen for the 100% transgenic animal (F3) with co-injection marker expression

The successful transgene integration can be easily observed based on the expression of co-injection marker. Since the integrated array is built up from all inject plasmid DNA, the expression of co-injection marker could refer to the existence of other co-injected DNA. However, the expression pattern of integrated transgene should be clarified in case of the known phenotype such as tissue specific with robust fluorescent signals. The screening of integrated array is usually done with the F3 progenies with 100% transgenic animals obtained from a single F2. The strong fluorescent marker can be observed under the fluorescent steromicroscope unless the integration method was proceeded with the phenotypic marker e.g. antibiotics or defective behaviors, normal stereoscope is feasible for screening procedure. In addition, the array integration without co-injection marker is possible in case the transgene of interest exhibits the distinguishable pattern of expression. There are several ways to determine the expression of the injected or integrated transgenes, however, the principle of such verification is to obtain the 100% transgene in the population.

The molecular verification of integrated transgene using PCR is based on the existence of undefined portion of array between tdTomato cutting site. Compared to the self-ligated tdTomato, the integrated gene would not give the amplicon from the PCR reaction. In this protocol, we introduce the 4-primer PCR reaction adjusted from the previous report (Malaiwong et al., 2023) in which 2 region of chromosome would be amplified.

PCR verification can be used when the candidate animals do not express the co-injection marker. There are 2 amplicons from the reaction: (1) the control band (0.3kb), eft-3 promotor, which represent the correct PCR amplification, (2) the excised tdTomato amplicon (0.7 kb) which represent the length of tdTomato landing site. The presence of tdTomato band indicates the non-integrated, the absence of tdTomato band indicates the integrated.

Forward1 (​Inaccessible DNA Sequence)

ttggtcttttattgtcaacttccattgg

Reverse1 (​Inaccessible DNA Sequence)

ccaacatgattagtcagatgaccaga

Forward2 (​Inaccessible DNA Sequence)

tttataatgaggtcaaacattcagtcccagcgtttt

Reverse2 (​Inaccessible DNA Sequence)

TTACTTGTACAGCTCGTCCATGC

Genotyping integrated candidate using PCR can be done following the instruction of particular commercial Kit.

Instead of using 2 primers, 4 primers are used.

Annealing temperature = 55C

Extension time = 40 sec - 1 min

Amplicon size = 0.3 kb and 0.7 kb

This protocol was described the culturing temperature of P0, F1, F2, and F3 at 25°C. However, this procedure cannot be proceeded with the temperature-sensitive phenotype of transgenes (from the genetic background or from the integrated gene). The appropriate temperature need to be considered prior to perform this method. Therefore, the time period of the screening step might be shifted. In addition, culturing P0 in 16°C decreases the efficiency of integration.

We firstly described about the integrated of the newly forming array with a single-shot injection. From this strategy, each extrachromosomal lines are independent and hold different transmission frequency. But, the integration using the existing array is different due to the prior selection of transmitted array before integration process. From this strategy, all generations (P0, F1, F2, and F3) which carry the transmitted array would give (1) the co-injection marker expression with tdTomato background, the consistent proportion of transmitted array in the F2 plates. From the latter, this screening step might required more petri dish for screening.

The integrated Cas9 is successfully used to encode the Cas9 inside the gonad. With this transgenic background (oxSi1091[mex-5p::Cas9(smu-2 introns) unc-119(+)] II), the integration of transgene on chromosome II is limited due to the gene proximity. Also, the integrated line from this strategy need to be outcrossed for eliminating Cas9.